Vicarious Surgical (RBOT) EPS (Weighted Average and Diluted) (2021 - 2025)
Vicarious Surgical (RBOT) reported EPS (Weighted Average and Diluted) of -$1.86 for Q3 2025, up 35.86% year-over-year from -$1.37 in Q3 2024, and up 16.59% on a QoQ basis from -$2.23 in Q2 2025.
Vicarious Surgical (RBOT) has 5 years of EPS (Weighted Average and Diluted) data on file, last reported at -$1.86 in Q3 2025.
- Quarterly EPS (Weighted Average and Diluted) rose 35.86% year-over-year to -$1.86 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$9.04 (up 11.55% YoY) and the FY2024 annual result came in at -$10.74, up 26.44% from the prior year.
- EPS (Weighted Average and Diluted) climbed to -$1.86 in Q3 2025 per RBOT's latest filing, from -$2.23 in the prior quarter.
- Across five years, EPS (Weighted Average and Diluted) topped out at $0.33 in Q1 2022 and bottomed at -$3.04 in Q3 2023.
- The 5-year median for EPS (Weighted Average and Diluted) is -$1.83 (2023), against an average of -$1.36.
- The widest annual swing landed in 2022, when EPS (Weighted Average and Diluted) surged 650.0%; it then plunged 2058.33% in 2024.
- Tracing RBOT's EPS (Weighted Average and Diluted) over 5 years: stood at -$0.49 in 2021, then jumped by 59.18% to -$0.2 in 2022, then sank by 815.0% to -$1.83 in 2023, then dropped by 28.42% to -$2.35 in 2024, then increased by 20.85% to -$1.86 in 2025.
- Per Business Quant, the three latest RBOT EPS (Weighted Average and Diluted) figures stand at -$1.86 (Q3 2025), -$2.23 (Q2 2025), and -$2.6 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 2.24 |
| 10 | Vicarious Surgical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1.86 |
| Jun 30, 2025 | -2.23 |
| Mar 31, 2025 | -2.60 |
| Dec 31, 2024 | -2.35 |
| Sep 30, 2024 | -2.90 |
| Jun 30, 2024 | -2.59 |
| Mar 31, 2024 | -2.90 |
| Dec 31, 2023 | -1.83 |
| Sep 30, 2023 | -3.04 |
| Jun 30, 2023 | -0.12 |
| Mar 31, 2023 | -0.21 |
| Sep 30, 2022 | -0.20 |
| Jun 30, 2022 | -0.01 |
| Mar 31, 2022 | 0.33 |
| Sep 30, 2021 | -0.49 |
| Jun 30, 2021 | -0.08 |
| Mar 31, 2021 | -0.06 |